Ionis Pharmaceuticals, Inc. (IONS) Social Stream
IONIS PHARMACEUTICALS INC (IONS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IONS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 13 | $68 | $20 | $46.045 | $50.5 | -8.82% |
| 2021-12-07 | 13 | $68 | $20 | $45.409 | $50.5 | -10.08% |
| 2021-12-08 | 13 | $68 | $22 | $45.318 | $50.5 | -10.26% |
| 2021-12-28 | 13 | $68 | $22 | $45.136 | $50.5 | -10.62% |
| 2022-01-21 | 13 | $68 | $22 | $44.681 | $50.5 | -11.52% |
| 2022-02-24 | 13 | $68 | $22 | $43.772 | $50.5 | -13.32% |
| 2022-02-28 | 13 | $68 | $22 | $43.136 | $50.5 | -14.58% |
| 2022-03-01 | 15 | $68 | $22 | $43.591 | $50.5 | -13.68% |
| 2022-03-07 | 14 | $68 | $22 | $42.125 | $50.5 | -16.58% |
| 2022-03-24 | 13 | $68 | $22 | $41.708 | $50.5 | -17.41% |
| 2022-03-31 | 14 | $68 | $22 | $42.653 | $50.5 | -15.54% |
| 2022-04-13 | 14 | $68 | $22 | $42.423 | $50.5 | -15.99% |
| 2022-05-04 | 14 | $68 | $22 | $42.115 | $50.5 | -16.6% |
| 2022-06-13 | 13 | $68 | $22 | $42.583 | $50.5 | -15.68% |
| 2022-08-03 | 13 | $68 | $22 | $42.916 | $50.5 | -15.02% |
| 2022-08-04 | 13 | $68 | $22 | $43.333 | $50.5 | -14.19% |
| 2022-08-10 | 14 | $68 | $22 | $44.923 | $50.5 | -11.04% |
| 2022-08-13 | 14 | $68 | $22 | $46 | $50.5 | -8.91% |
| 2022-08-16 | 14 | $68 | $22 | $45.923 | $50.5 | -9.06% |
| 2022-10-14 | 13 | $64 | $22 | $46.333 | $50.5 | -8.25% |
| 2022-10-24 | 13 | $64 | $22 | $47 | $50.5 | -6.93% |
| 2022-11-04 | 12 | $64 | $22 | $45.818 | $50.5 | -9.27% |
| 2022-11-13 | 12 | $64 | $24 | $46.09 | $50.5 | -8.73% |
| 2022-11-30 | 13 | $64 | $24 | $46.636 | $50.5 | -7.65% |
| 2023-01-03 | 13 | $64 | $24 | $45.181 | $50.5 | -10.53% |
| 2023-01-06 | 13 | $64 | $24 | $45.727 | $50.5 | -9.45% |
| 2023-01-26 | 13 | $64 | $24 | $45.909 | $50.5 | -9.09% |
| 2023-02-08 | 13 | $64 | $24 | $46 | $50.5 | -8.91% |
| 2023-02-23 | 16 | $67 | $24 | $46.153 | $50.5 | -8.61% |
| 2023-03-21 | 15 | $67 | $24 | $43.846 | $50.5 | -13.18% |
| 2023-04-13 | 15 | $67 | $24 | $44 | $50.5 | -12.87% |
| 2023-04-25 | 15 | $67 | $24 | $44.076 | $50.5 | -12.72% |
| 2023-05-04 | 16 | $88 | $26 | $47.428 | $50.5 | -6.08% |
| 2023-05-10 | 15 | $88 | $26 | $47.428 | $50.5 | -6.08% |
| 2023-06-06 | 17 | $88 | $26 | $47.428 | $50.5 | -6.08% |
| 2023-06-07 | 17 | $88 | $26 | $48.133 | $50.5 | -4.69% |
| 2023-07-24 | 16 | $88 | $26 | $48.071 | $50.5 | -4.81% |
| 2023-07-26 | 16 | $88 | $26 | $48.214 | $50.5 | -4.53% |
| 2023-07-31 | 16 | $88 | $26 | $50.285 | $50.5 | -0.43% |
| 2023-08-10 | 16 | $88 | $27 | $49.928 | $50.5 | -1.13% |
| 2023-09-18 | 16 | $88 | $27 | $50.285 | $50.5 | -0.43% |
| 2023-09-26 | 16 | $88 | $27 | $50.428 | $50.5 | -0.14% |
| 2023-10-12 | 17 | $88 | $27 | $51.466 | $50.5 | 1.91% |
| 2023-10-16 | 17 | $88 | $27 | $51.733 | $50.5 | 2.44% |
| 2023-10-20 | 17 | $88 | $27 | $51.933 | $50.5 | 2.84% |
| 2023-10-25 | 17 | $88 | $27 | $53.2 | $50.5 | 5.35% |
| 2023-11-03 | 18 | $88 | $27 | $53.25 | $50.5 | 5.45% |
| 2023-11-06 | 18 | $88 | $29 | $54.187 | $50.5 | 7.3% |
| 2023-11-14 | 19 | $88 | $29 | $54.764 | $50.5 | 8.44% |
| 2023-12-17 | 19 | $88 | $29 | $55.058 | $50.5 | 9.03% |
| 2023-12-19 | 19 | $88 | $29 | $55.352 | $50.5 | 9.61% |
| 2023-12-22 | 19 | $88 | $29 | $55.47 | $50.5 | 9.84% |
The Trend in the Analyst Price Target
Over the past 43 months, IONS's average price target has gone down $12.59.
IONS reports an average of 18.48% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-06 | 17 | 88 | 26 | 47.428 | 43.33 | 9.46% |
| 2023-06-06 | 16 | 88 | 26 | 47.428 | 43.33 | 9.46% |
| 2023-09-18 | 16 | 88 | 27 | 50.285 | 42.93 | 17.13% |
| 2023-09-26 | 16 | 88 | 27 | 50.428 | 46.28 | 8.96% |
| 2023-11-14 | 19 | 88 | 29 | 54.764 | 49.15 | 11.42% |
IONS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.11 | 9 | 2 | 6 | 1 | 1 | 19 |
The Trend in the Broker Recommendations
Over the past 19 months, IONS's average broker recommendation rating improved by 0.53.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IONS as an investment opportunity.
- In the context of all US stocks, IONIS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -5696.61% of them.
- In the context of Pharmaceutical Products stocks, IONIS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 690.9% of them.
- IONIS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 5589.54% of Pharmaceutical Products stocks.
- IONIS PHARMACEUTICALS INC's average analyst price target is greater than 1831.95% of stocks in the large market cap category.
In the Pharmaceutical Products industry, SRPT, MRVI, and ABCL are the three stocks most similar to IONIS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is IONS a Buy, Hold or Sell? See the POWR Ratings now!